Detalles de la búsqueda
1.
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 153-161, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112166
2.
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 555-564, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35230585
3.
Multidisciplinary approach to low-dose CT screening for lung cancer in a metropolitan community.
Fam Pract
; 37(1): 25-29, 2020 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31273379
4.
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 565, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507135
5.
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study.
Lancet Oncol
; 14(12): 1216-25, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24095299
6.
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Cancer
; 119(14): 2555-63, 2013 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23605883
7.
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
J Clin Oncol
; 41(6): 1285-1295, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260832
8.
The Correlative Strength of Objective Physical Assessment Against the ECOG Performance Status Assessment in Individuals Diagnosed With Cancer.
Phys Ther
; 100(3): 416-428, 2020 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043132
9.
Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
Clin Breast Cancer
; 8(3): 257-63, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650156
10.
Molecular targeting in cancer therapy: can we fulfill the promise?
Oncology (Williston Park)
; 26(11): 1040, 1042, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23330343
11.
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop.
J Clin Oncol
; 35(27): 3153-3159, 2017 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28737972
12.
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.
J Clin Oncol
; 23(16): 3697-705, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15738537
13.
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors.
Clin Cancer Res
; 19(1): 268-78, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23136196
14.
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer.
Lung Cancer
; 74(3): 474-80, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21680048
Resultados
1 -
14
de 14
1
Próxima >
>>